Skip to main content
. Author manuscript; available in PMC: 2020 Oct 2.
Published in final edited form as: Am J Clin Oncol. 2020 Oct;43(10):685–689. doi: 10.1097/COC.0000000000000727

FIGURE 1.

FIGURE 1.

Oncoprint diagram: SPOP, SPTA1, AR (prostate cancer related), APOE, BIN1, and CD2AP (Alzheimer’s disease related) in 489 primary prostate cancer samples. Alterations are present in 12% of SPOP, 4% of BIN1, 6% of SPTA1, 0.8% of CD2AP, 1% of APOE, and 1.4% of AR. Significantly co-occurrent alterations are present in the gene pairs SPOP/BIN1 and SPTA1/CD2AP (cBioportal).